Zygraich N, Vascoboinic E, Huygelen C
Dev Biol Stand. 1976;33:379-83.
The persistence of systemic and local antibodies was studied after two intranasal administrations of the vaccine, six weeks apart. Systemic antibodies to I.B.R. and adenovirus 3 evoked by the vaccine were still present 21 weeks following the second dose of the vaccine. Inconslusive results were obtained regarding the persistence of systemic and local PI-3 antibodies because of an intercurrent natureal PI-3 infection occurring during the observation period. Local antibodies to adenovirus type 3 were found in a high percentage of vaccinated animals 21 weeks after the second dose of the vaccine, whereas local antibodies to I.B.R. remained detectable in 50% of the animals eight weeks after thesecond dose. The results of a challenge study 21 weeks after revaccination show that the presence of local and systemic antibodies prevent the multiplication of PI-3 and BAV-3 in the upper respiratory tract. Protection against I.B.R. was achieved in the absence of detectable local antibodies.
在间隔六周进行两次鼻内接种疫苗后,研究了全身和局部抗体的持久性。疫苗诱发的针对传染性牛鼻气管炎(I.B.R.)和腺病毒3的全身抗体在第二剂疫苗接种后21周仍存在。由于在观察期内发生了并发的自然PI-3感染,关于全身和局部PI-3抗体的持久性得出了不确定的结果。在第二剂疫苗接种21周后,在高比例的接种动物中发现了针对3型腺病毒的局部抗体,而在第二剂疫苗接种八周后,50%的动物中仍可检测到针对I.B.R.的局部抗体。再次接种疫苗21周后的攻毒研究结果表明,局部和全身抗体的存在可防止PI-3和BAV-3在上呼吸道中增殖。在没有可检测到的局部抗体的情况下实现了对I.B.R.的保护。